The Statistical Center of the International Bone Marrow Transplant Registry (IBMTR) and the Autologous Blood and Marrow Transplant Registry of North America (ABMTR) coordinates an international effort to collect and analyze data on outcome of blood and bone marrow (hematopoietic stem cell) transplants. The IBMTR, established in 1972, and the ABMTR, established in 1990, involve greater than 400 transplant centers in 47 countries. Participating centers submit data on consecutive transplants to the IBMTR/ABMTR Statistical Center. The Registries have data for greater than 65,000 transplants. These data are used for determining transplant results in specific clinical situations, identifying prognostic factors, comparing transplant regimens, comparing transplant with non-transplant therapy, assessing intercenter variability in diagnosis, practice and outcome, evaluating transplant costs and cost- effectiveness, planning clinical trials or treatment protocols, and developing approaches to evaluating transplant outcome. Statistical Center personnel have a strong record of expert and innovative analyses of these and other issues using IBMTR/ABMTR data. The proposed grant will support continued development of this unique resource of data and statistical expertise. The proposal outlines several enhancements to the Statistical Center's data collection, entry and management system, including addition of cost information, that will ensure availability of demographic, medical and financial data on a large and representative group of transplant recipients for use by the scientific community. The proposal includes several strategies to increase awareness of this resource and enhance its availability to investigators and health policy makers, including development of a public use database. The project will also develop statistical methodologies appropriate for unbiased and efficient analyses of transplant data and provide expert statistical support for studies using IBMTR/ABMTR data.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Resource-Related Research Projects--Cooperative Agreements (U24)
Project #
5U24CA076518-04
Application #
6362642
Study Section
Special Emphasis Panel (ZCA1-RLB-7 (O6))
Program Officer
Jensen, Lee Ann
Project Start
1998-03-01
Project End
2003-02-28
Budget Start
2001-03-01
Budget End
2002-02-28
Support Year
4
Fiscal Year
2001
Total Cost
$2,304,566
Indirect Cost
Name
Medical College of Wisconsin
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073134603
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Stiff, Patrick J; Montesinos, Pau; Peled, Tony et al. (2018) Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit Transplantation. Biol Blood Marrow Transplant 24:1463-1470
Hill, Brian T; Ahn, Kwang Woo; Hu, Zhen-Huan et al. (2018) Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia. Biol Blood Marrow Transplant 24:581-586
Pulsipher, Michael A; Logan, Brent R; Chitphakdithai, Pintip et al. (2018) Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study. Biol Blood Marrow Transplant :
Ahn, Kwang Woo; Kim, Soyoung (2018) Variable selection with group structure in competing risks quantile regression. Stat Med 37:1577-1586
Myers, Regina M; Hill, Brian T; Shaw, Bronwen E et al. (2018) Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma. Cancer 124:816-825
Drobyski, William R; Szabo, Aniko; Zhu, Fenlu et al. (2018) Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease. Haematologica 103:717-727
Sullivan, Keith M; Majhail, Navneet S; Bredeson, Christopher et al. (2018) Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 24:1961-1964
Stroncek, David F; Shaw, Bronwen E; Logan, Brent R et al. (2018) Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less. Biol Blood Marrow Transplant 24:175-184
Kumar, Anita J; Kim, Soyoung; Hemmer, Michael T et al. (2018) Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants. Blood Adv 2:1022-1031
Alousi, Amin; Wang, Tao; Hemmer, Michael T et al. (2018) Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival. Biol Blood Marrow Transplant :

Showing the most recent 10 out of 641 publications